Physician profile
Stephen Hamilton
NPI 1083678577
$8,430.12
in general payments reported to CMS, 2019-2025
28 companies · $1,243 in 2025
The $1,243 reported for 2025 was more than what 76% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $716 · 2020: $203 · 2021: $412 · 2022: $156 · 2023: $278 · 2024: $5,421 · 2025: $1,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,027 · Food and Beverage: $1,287 · Long Term Medical Supply Or Device Loan: $600 · Entertainment: $28.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,027.00 |
| Food and Beverage | $1,287.41 |
| Long Term Medical Supply Or Device Loan | $600.00 |
| Entertainment | $28.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Digital Innovations LLC | $5,027.00 | 2024 | Veracity Surgical |
| Ocular Therapeutix, INC. | $805.10 | 2019-2025 | Dextenza |
| Bausch & Lomb Americas INC. | $298.00 | 2022-2025 | Vyzulta, Miebo, Envista Mx60 Iol |
| Alcon Vision LLC | $236.69 | 2019-2025 | Clareon, Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $224.75 | 2019 | |
| Glaukos Corporation | $193.58 | 2022-2024 | Ce-Marked Kxla System, Istent Inject Trabecular Micro-Bypass System |
| Novartis Pharmaceuticals Corporation | $180.62 | 2019-2023 | |
| Allergan, INC. | $174.04 | 2019-2022 | |
| Abbvie INC. | $164.98 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $160.21 | 2019-2021 | |
| Biotissue Holdings INC. | $136.93 | 2019-2024 | |
| Dompe US, INC. | $126.22 | 2019-2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $115.38 | 2019-2020 | |
| New World Medical,INC. | $106.53 | 2023-2025 | Kahook Dual Blade, Streamline, Clearpath |
| Carl Zeiss Meditec USA, INC. | $87.93 | 2021 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $72.57 | 2021 | |
| Beaver-Visitec International, INC. | $55.85 | 2021 | |
| Oyster Point Pharma, INC. | $40.86 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $30.78 | 2025 | Xdemvy |
| Nova Eye, INC. | $28.22 | 2025 | |
| Rxsight INC | $26.15 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Mallinckrodt Hospital Products INC. | $25.64 | 2020 | |
| Sun Pharmaceutical Industries INC. | $21.94 | 2020 | |
| Thea Pharma INC. | $20.53 | 2025 | Iyuzeh |
| Astellas Pharma US INC | $19.33 | 2025 | Izervay |
| Mallinckrodt Enterprises LLC | $18.72 | 2019 | |
| Medline Industries LP | $15.85 | 2021 | |
| Shire North American Group INC | $15.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.